Vaccines in lymphoma

Clin Adv Hematol Oncol. 2004 Jul;2(7):424, 427.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Anti-Idiotypic / immunology
  • Antibodies, Anti-Idiotypic / therapeutic use
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Antigens, Neoplasm / immunology
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Forecasting
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunoglobulin Idiotypes / immunology
  • Immunotherapy, Active*
  • Lymphoma / genetics
  • Lymphoma / immunology
  • Lymphoma / therapy*
  • Mice
  • Rituximab
  • Species Specificity
  • Treatment Outcome
  • Tumor Burden

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antigens, Neoplasm
  • Cancer Vaccines
  • Immunoglobulin Idiotypes
  • Rituximab